Acceder

Bibliografías temáticas / Disease prevention / Artículos de revistas

Artículos de revistas sobre el tema "Disease prevention"

Siga este enlace para ver otros tipos de publicaciones sobre el tema: Disease prevention.

Autor: Grafiati

Publicado: 4 de junio de 2021

Última modificación: 29 de julio de 2024

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Disease prevention".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Shakhnoza, Iskandarova y Amilova Asalya. "PREVENTION OF CORONARY HEART DISEASE". American Journal of Medical Sciences and Pharmaceutical Research 04, n.º 04 (1 de abril de 2022): 19–21. http://dx.doi.org/10.37547/tajmspr/volume04issue04-05.

Texto completo

Resumen

Primary prevention, based on healthy lifestyle habits that prevent the emergence of risk factors, is the preferred method of reducing cardiovascular risk. Reducing the prevalence of obesity is the most urgent task, and it is pleiotropic in that it affects blood pressure, lipid profile, glucose metabolism, inflammation, progression of atherothrombotic disease. Physical activity also improves several risk factors, with the added potential to lower heart rate.

Los estilos APA, Harvard, Vancouver, ISO, etc.

2

&NA;. "DISEASE PREVENTION". American Journal of Nursing 99, n.º 8 (agosto de 1999): 10. http://dx.doi.org/10.1097/00000446-199908000-00004.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

3

Pignone, Michael P. y Kirsten Bibbins-Domingo. "Disease Prevention". Medical Clinics of North America 101, n.º 4 (julio de 2017): i. http://dx.doi.org/10.1016/s0025-7125(17)30070-6.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

4

Shubrook, Jay H. "Disease prevention". Osteopathic Family Physician 3, n.º 5 (septiembre de 2011): 181. http://dx.doi.org/10.1016/j.osfp.2011.07.003.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

5

Selby, JoeV. "DISEASE PREVENTION". Lancet 341, n.º 8847 (marzo de 1993): 728–29. http://dx.doi.org/10.1016/0140-6736(93)90493-z.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

6

SCHAPIRA, DAVID V. "Disease Prevention". Archives of Internal Medicine 149, n.º 6 (1 de junio de 1989): 1253. http://dx.doi.org/10.1001/archinte.1989.00390060007001.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

7

Zuo, Tongzhuo. "The Current Status of Occupational Disease Prevention". Learning & Education 9, n.º 2 (10 de noviembre de 2020): 6. http://dx.doi.org/10.18282/l-e.v9i2.1385.

Texto completo

Resumen

Occupational diseases are disorders of health resulting from conditions related to the workplace. There are 2.3 million deaths annually for reasons attributed to work globally, primarily to chemicals or dust. China has the largest working population in the world, with 776 million employed in 2018. According to the National Health Commission, about 12 million companies were found to have occupational-disease-inductive factors and at least 200 million people are exposed to occupational disease hazards. Preventing occupational diseases is a serious worldwide challenge. On the other hand, many developed countries already have rich experience in the prevention and treatment of various occupational diseases. They have set up various occupational disease prevention agencies and formulated strict occupational disease prevention systems. It is necessary for developing countries to learn from their advanced control measures.

Los estilos APA, Harvard, Vancouver, ISO, etc.

8

Mirzakarimova, Farida, Svetlana Kaleda, Natalia Polikarpova y Abdumurad Babadjanov. "NONALCOHOLIC FATTY LIVER DISEASE -SOME ASPECTS OF PREVENTION". UZBEK MEDICAL JOURNAL 2, n.º 2 (28 de febrero de 2021): 15–24. http://dx.doi.org/10.26739/2181-0664-2021-2-3.

Texto completo

Resumen

Nowadays, NAFLD is considered one of the leading causes of chronic liver diseases globally.This is probably becausea patient with NAFLD usually had more severe diseases -diabetes mellitus type 2 (DM-2), metabolic syndrome, etc. On the one hand, after it was established that insulin resistance underlies these metabolic diseases and, on the other hand, that compensationfor these conditions does not eliminate NAFLD, and the presence of NAFLD worsens the course of the underlying disease, interest in its study increased significantly. The development of NAFLD is increasingly associated with the hypothesis of multifactorial parallel effects, or "multiple parallel hits" ("multiple parallel hits").

Los estilos APA, Harvard, Vancouver, ISO, etc.

9

Maeda, Kazuo. "Prevention of Choriocarcinoma after Postmolar Persistent Trophoblastic Disease". Women Health Care and Issues 2, n.º 2 (10 de diciembre de 2019): 01. http://dx.doi.org/10.31579/2642-9756/009.

Texto completo

Resumen

Also Chemotherapy was progresses in choriocarcinoma after Methotrexate, still its prevention with the treatment of persistent trophoblastic dusase is needed after molar treatment.The prevention was achieved with particular MTX treatment of persistenttrophoblastic disease.

Los estilos APA, Harvard, Vancouver, ISO, etc.

10

Aslam, Dr Imran, Yuldashev Soatboy Jiyanboyevich y Abdurakhmanova Zamira Ergashboevna. "Prevention & Treatment Of Cardiovascular Diseases". American Journal of Medical Sciences and Pharmaceutical Research 03, n.º 06 (10 de junio de 2021): 180–88. http://dx.doi.org/10.37547/tajmspr/volume03issue06-28.

Texto completo

Resumen

Cardiovascular disease is a significant problem that humans have always faced, affecting thousands of people's lives and health and taking the lives of many people. Many medical institutions and researchers have regarded it as a significant problem in overcoming the cardiovascular disease.1 Much attention has been paid, so the prevention and treatment level in this area has also been rapidly improved. However, cardiovascular disease still cannot be prevented or treated fundamentally, and it is still a significant danger to human health. All people still hope for breakthrough results in cardiovascular disease.2 This article analyzes the prevention and treatment of cardiovascular diseases, and has obtained a series of practical and reliable conclusions.

Los estilos APA, Harvard, Vancouver, ISO, etc.

11

Pipe, Andrew. "Cardiovascular disease prevention". Current Opinion in Cardiology 33, n.º 5 (septiembre de 2018): 498–99. http://dx.doi.org/10.1097/hco.0000000000000551.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

12

Van Camp, G. "Cardiovascular disease prevention". Acta Clinica Belgica 69, n.º 6 (31 de agosto de 2014): 407–11. http://dx.doi.org/10.1179/2295333714y.0000000069.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

13

Schargrodsky, Herman, María C. Escobar y Edgardo Escobar. "Cardiovascular Disease Prevention". Circulation 98, n.º 20 (17 de noviembre de 1998): 2103–4. http://dx.doi.org/10.1161/01.cir.98.20.2103.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

14

Rendall, G. "Bee disease prevention". Veterinary Record 122, n.º 13 (26 de marzo de 1988): 311–12. http://dx.doi.org/10.1136/vr.122.13.311.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

15

Kapustin, Jane. "Chronic Disease Prevention". Journal for Nurse Practitioners 6, n.º 1 (enero de 2010): 6. http://dx.doi.org/10.1016/j.nurpra.2009.09.017.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

16

Keevil, Jon G., James H. Stein y Patrick E. McBride. "Cardiovascular disease prevention". Primary Care: Clinics in Office Practice 29, n.º 3 (septiembre de 2002): 667–96. http://dx.doi.org/10.1016/s0095-4543(02)00012-x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

17

Burns, Jackie. "Pneumococcal disease prevention". Primary Health Care 12, n.º 8 (octubre de 2002): 24–26. http://dx.doi.org/10.7748/phc.12.8.24.s21.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

18

Dietz, William H., Clifford E. Douglas y Ross C. Brownson. "Chronic Disease Prevention". JAMA 316, n.º 16 (25 de octubre de 2016): 1645. http://dx.doi.org/10.1001/jama.2016.14370.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

19

Pawar, Neha madhukar y Archana Kulkarni. "CONCEPT OF VYADHIKSHAMATVA IN AYRVEDA". International Journal of Research -GRANTHAALAYAH 8, n.º 8 (30 de agosto de 2020): 239–43. http://dx.doi.org/10.29121/granthaalayah.v8.i8.2020.1064.

Texto completo

Resumen

For prevention of diseases, Ayurveda had advocated the adherence to concepts like dina charya, ritu charya, sadvritta , Na vega dharan etc. these measures are useful in preventing the lifestyle related diseases but for preventing the Aupsargik rogas (communicable diseases), Janapada dhwansa rogas (epidemic diseases), Krumij Roga (Infectious diseases), Asatmyaj roga (allergic disorders), the concept of Vyadhikshamtva (Immunity) is propagated by the Ayurvedic science [1]. According to the concept of Ojas or Vyadhikshamatva or Bala (immunity), the body‟s resistance is of tremendous importance in the daily welfare of living beings not only for disease prevention but also for rapid recovery after disease affliction. [2] Ayurveda propounds that prevention is an equally important aspect of disease management as cure and thus, strengthening the immune system, is a natural way to help the body fight against the disease-causing pathogens. Acharyas promoted the use of Rasayana (Rejuvenation) to enhance ojas and vyadhikshamatva (immunity). This article is an effort to present Ayurvedic concepts of Vyadhishamatva.

Los estilos APA, Harvard, Vancouver, ISO, etc.

20

Turner, Chris. "Prevention, prevention". Faculty Dental Journal 10, n.º 3 (julio de 2019): 94–97. http://dx.doi.org/10.1308/rcsfdj.2019.94.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

21

O'g'li, Roxibjonov Adhamjon Raxmatjon. "PREVENTION OF DILATED CARDIOMYOPATHY DISEASE MEASURES TO TREAT IT". International Journal of Medical Sciences And Clinical Research 3, n.º 12 (1 de diciembre de 2023): 13–18. http://dx.doi.org/10.37547/ijmscr/volume03issue12-03.

Texto completo

Resumen

Dilated cardiomyopathy is myocardial dysfunction causing heart failure in which ventricular dilation and systolic dysfunction predominate. Symptoms include dyspnea, fatigue, and peripheral edema. Diagnosis is clinical and by elevated natriuretic peptides, chest x-ray, echocardiography, and MRI. Treatment is directed at the cause. If heart failure is progressive and severe, cardiac resynchronization therapy, implantable cardioverter-defibrillator, repair of moderate to severe valvular regurgitation, left ventricular assist device, or heart transplantation may be needed.

Los estilos APA, Harvard, Vancouver, ISO, etc.

22

Najmitdinovna, Kudratova Gulsara y Ibragimova Yulduz Botyrovna. "PREVENTION OF BRONCHIAL ASTHMA IN CHILDREN AND TEENAGERS". American Journal Of Biomedical Science & Pharmaceutical Innovation 4, n.º 3 (1 de marzo de 2024): 52–55. http://dx.doi.org/10.37547/ajbspi/volume04issue03-07.

Texto completo

Resumen

Bronchial asthma is considered a chronic disease and causes many health problems for the population. The disease is based on a genetic predisposition. Children whose parents have allergic diseases (bronchial asthma, allergic rhinitis, atopic dermatitis, eczema, Quincke's edema, etc.) have asthma in the first year of life the tendency to develop the disease is high. (25% if father or mother is sick with allergic diseases, 50% if allergic diseases are observed in both father and mother).

Los estilos APA, Harvard, Vancouver, ISO, etc.

23

Fugh-Berman, A. y S. Epstein. "Tamoxifen: disease prevention or disease substitution?" Lancet 340, n.º 8828 (noviembre de 1992): 1143–45. http://dx.doi.org/10.1016/0140-6736(92)93161-f.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

24

Berra, K., N. Houston Miller y J. M. Fair. "Cardiovascular Disease Prevention and Disease Management". Journal of Cardiopulmonary Rehabilitation 26, n.º 4 (julio de 2006): 197–206. http://dx.doi.org/10.1097/00008483-200607000-00001.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

25

Dmochowski, Tymon. "Green infrastructure as a disease prevention and rehabilitation tool". Przegląd Naukowy Inżynieria i Kształtowanie Środowiska 28, n.º 4 (29 de diciembre de 2019): 682–89. http://dx.doi.org/10.22630/pniks.2019.28.4.61.

Texto completo

Resumen

This article tackles with the problem of preventing diseases caused by physical inactivity. It offers a brief review of deadliest diseases and defi nes critical role of green public spaces in their prevention. Article presents patient treatment costs, in contrast to the costs of organizing green public spaces, suggesting substantial relief from economic burden sustained by national health fund by offering green public spaces designed specifi cally for disease prevention instead of conventional treatment.

Los estilos APA, Harvard, Vancouver, ISO, etc.

26

Vakrilova Becheva, Maria Stamova, Angelina Georgieva Kirkova-Bogdanova, Stefka Аchkova Ivanova, Petar Jordanov Atanasov, Mariya Sevdelinova Chaneva y Valentina Boyanova Petkova. "Prevention of cardiovascular diseases". Pharmacia 70, n.º 4 (27 de octubre de 2023): 1243–47. http://dx.doi.org/10.3897/pharmacia.70.e114071.

Texto completo

Resumen

Cardiovascular diseases (CVD) are socially significant diseases due to high morbidity and loss of people of working age. In Bulgaria, they are the leading cause of mortality among the population and are a consequence of the effect of cardiovascular risk factors. The draft of the National Health Strategy (NHS) 2021–2030 reports on their wide distribution, as well as on the insufficient knowledge, skills and motivation for their prevention and control. The purpose of this review is to address the prevention of cardiovascular disease, which is a significant problem worldwide. Prevention goals for patients with established cardiovascular disease and those at high risk include smoking cessation, healthy eating, physical activity, and lowering body mass index. There are various methods that are part of health promotion to reduce CVD risks. These methods include motivational interviewing, non-pharmacological means, the use of certain medications for CVD prevention, as well as physical activity. Strategies for effective primary prevention refer to engaging the patient to change their lifestyle and identifying risk factors, while secondary prevention is aimed at activities to detect the disease early and to slow down its progression. It is necessary to create a strategy for timely preventive actions with a view to preventing the negative influence of risk factors and improving people‘s heart health.

Los estilos APA, Harvard, Vancouver, ISO, etc.

27

Chew, Emily Y. "Disease Management by Prevention". Disease Management and Health Outcomes 6, n.º 5 (1999): 279–90. http://dx.doi.org/10.2165/00115677-199906050-00005.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

28

Traynor, Kate. "Disease prevention gains attention". American Journal of Health-System Pharmacy 66, n.º 15 (1 de agosto de 2009): 1336–38. http://dx.doi.org/10.2146/news090063.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

29

Lavie, Carl J., Ray W. Squires y Gerald T. Gau. "Prevention of cardiovascular disease". Postgraduate Medicine 81, n.º 5 (abril de 1987): 52–72. http://dx.doi.org/10.1080/00325481.1987.11699780.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

30

Tenenbaum, Ariel, Mohammed Morad y Joav Merrick. "Cardiovascular disease and prevention". International Journal of Adolescent Medicine and Health 26, n.º 4 (1 de noviembre de 2014): 457–58. http://dx.doi.org/10.1515/ijamh-2014-0004.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

31

Bauer, Michael y Dominic Coppolo. "Agricultural Lung Disease: Prevention". Seminars in Respiratory and Critical Care Medicine 14, n.º 01 (enero de 1993): 83–89. http://dx.doi.org/10.1055/s-2007-1006311.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

32

Coralli, Connie. "Disease Prevention/Health Promotion". Nurse Practitioner 15, n.º 2 (febrero de 1990): 74. http://dx.doi.org/10.1097/00006205-199002000-00018.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

33

Gardner, Pierce. "Prevention of Meningococcal Disease". New England Journal of Medicine 355, n.º 14 (5 de octubre de 2006): 1466–73. http://dx.doi.org/10.1056/nejmcp063561.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

34

Kornhuber, J. "Prevention of Alzheimer's Disease". Fortschritte der Neurologie · Psychiatrie 73, n.º 6 (junio de 2005): 315–16. http://dx.doi.org/10.1055/s-2004-830309.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

35

Filley, Christopher M. "Alzheimer disease prevention: Table". Neurology: Clinical Practice 5, n.º 3 (29 de diciembre de 2014): 193–200. http://dx.doi.org/10.1212/cpj.0000000000000108.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

36

Zimmerman, Marcia. "Phytochemicals and Disease Prevention". Alternative and Complementary Therapies 1, n.º 3 (abril de 1995): 154–57. http://dx.doi.org/10.1089/act.1995.1.154.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

37

Szekely, C. A., J. C. S. Breitner y P. P. Zandi. "Prevention of Alzheimer's disease". International Review of Psychiatry 19, n.º 6 (enero de 2007): 693–706. http://dx.doi.org/10.1080/09540260701797944.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

38

Thal, Leon J. "Prevention of Alzheimer Disease". Alzheimer Disease & Associated Disorders 20, Supplement 2 (julio de 2006): S97—S99. http://dx.doi.org/10.1097/00002093-200607001-00015.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

39

Bloomgarden, Z. T. "Prevention of Cardiovascular Disease". Diabetes Care 30, n.º 2 (26 de enero de 2007): 423–31. http://dx.doi.org/10.2337/dc07-zb02.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

40

&NA;. "Prevention of heart disease". Inpharma Weekly &NA;, n.º 833 (abril de 1992): 3. http://dx.doi.org/10.2165/00128413-199208330-00004.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

41

Paixao, Andre R. M., Colby R. Ayers, Jarett D. Berry, James A. de Lemos y Amit Khera. "Atherosclerotic Cardiovascular Disease Prevention". Circulation: Cardiovascular Quality and Outcomes 7, n.º 5 (septiembre de 2014): 778–79. http://dx.doi.org/10.1161/circoutcomes.114.001139.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

42

Holmes, Julia S., Irma E. Arispe y Ernest Moy. "Heart Disease and Prevention". Medical Care 43, Supplement (marzo de 2005): I—33—I—41. http://dx.doi.org/10.1097/00005650-200503001-00006.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

43

Porena, M., P. Guiggi y C. Micheli. "Prevention of Stone Disease". Urologia Internationalis 79, n.º 1 (2007): 37–46. http://dx.doi.org/10.1159/000104440.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

44

Couch, Patricia y Gary E. Johnson. "Prevention of Lyme disease". American Journal of Health-System Pharmacy 49, n.º 5 (1 de mayo de 1992): 1164–73. http://dx.doi.org/10.1093/ajhp/49.5.1164.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

45

King, Kathryn M. y Heather M. Arthur. "Coronary Heart Disease Prevention". Journal of Cardiovascular Nursing 18, n.º 4 (septiembre de 2003): 274–81. http://dx.doi.org/10.1097/00005082-200309000-00006.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

46

Hill, Martha N. y George A. Mensah. "Global Cardiovascular Disease Prevention". Journal of Cardiovascular Nursing 26, Supplement (julio de 2011): S4. http://dx.doi.org/10.1097/jcn.0b013e318213efe4.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

47

Berra, Kathy, Barbara Fletcher, Laura L. Hayman y Nancy Houston Miller. "Global Cardiovascular Disease Prevention". Journal of Cardiovascular Nursing 28, n.º 6 (2013): 505–13. http://dx.doi.org/10.1097/jcn.0b013e31826b6822.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

48

Schafer, Tara E. y Steven M. Adair. "PREVENTION OF DENTAL DISEASE". Pediatric Clinics of North America 47, n.º 5 (octubre de 2000): 1021–42. http://dx.doi.org/10.1016/s0031-3955(05)70256-x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

49

Rose, Geoffrey, M. P. H. Doublet Stewart, ChristopherA Birt, PeterR Croft y PatrickF James. "CORONARY HEART DISEASE PREVENTION". Lancet 332, n.º 8619 (noviembre de 1988): 1081–82. http://dx.doi.org/10.1016/s0140-6736(88)90102-x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

50

Mccormick, JamesS, Petr Skrabanek, J. A. Lee y R. C. Cottrell. "CORONARY HEART DISEASE PREVENTION". Lancet 332, n.º 8621 (noviembre de 1988): 1189–90. http://dx.doi.org/10.1016/s0140-6736(88)90252-8.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!